Clinical Research Directory
Browse clinical research sites, groups, and studies.
ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma
Sponsor: Technical University of Munich
Summary
Reduced activity levels and reduced muscular strength could severely impair the activities of daily living (ADLs) in pediatric leukemia and Non-Hodgkin lymphoma patients. Increased muscle strength is associated with improved accomplishment of ADLs and consequently greatest possible normality, autonomy and mobility. This associated investigation to the study with the ClinicalTrials.gov Identifier NCT03934060 aims at collecting data in a comparison cohort with respect to ADLs in children and adolescents who did not receive a standardized strenght training intervention during the whole course of treatment.
Official title: Activities of Daily Living at the End of Acute Treatment for Acute Leukemia or Non-Hodgkin Lymphona During Childhood and Adolescence
Key Details
Gender
All
Age Range
4 Years - 18 Years
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2022-04-19
Completion Date
2027-12-31
Last Updated
2026-08-19
Healthy Volunteers
No
Conditions
Interventions
Assessment of the accomplishment regarding Activities of Daily Living at the end of acute treatment
Participants perform a test battery to assess the capability to accomplish Activities of Daily Living that includes a standardized and validated questionnaire, a parcour with tasks based on Activities of Daily Living and a motor performance test.
Locations (1)
Kinderklinik München Schwabing, TUM School of Medicine, Department of Paediatrics and Children's Cancer Research Center, Technical University of Munich, Germany
Munich, Germany